SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?


To: finbar who wrote (1470)2/25/2007 8:25:32 PM
From: finbar  Read Replies (1) | Respond to of 1475
 
not very scientific, but on the MEDI website they have within the last 2 weeks advanced the little bar that represents the progress of Medi-507 - which they call sipluzamab to the phase II crosshair. BTRN gets a 1 or 2 mm milestone if and when this happens - never been able to tell if the compound is 1st or 2nd generation which accounts for the difference in milestone payable.